AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 20 filers reported holding AMBRX BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,560 | +84.5% | 702,291 | 0.0% | 0.36% | -3.8% |
| Q1 2023 | $6,264 | +28.2% | 702,291 | -67.4% | 0.37% | +36.3% |
| Q4 2022 | $4,886 | -99.8% | 2,152,291 | 0.0% | 0.27% | +175.8% |
| Q3 2022 | $2,324,000 | -59.3% | 2,152,291 | 0.0% | 0.10% | -67.5% |
| Q2 2022 | $5,704,000 | -35.7% | 2,152,291 | 0.0% | 0.30% | -17.8% |
| Q1 2022 | $8,867,000 | -54.4% | 2,152,291 | 0.0% | 0.37% | -29.6% |
| Q4 2021 | $19,435,000 | +69.4% | 2,152,291 | +153.2% | 0.53% | +105.1% |
| Q3 2021 | $11,475,000 | -31.1% | 850,000 | 0.0% | 0.26% | -24.0% |
| Q2 2021 | $16,660,000 | – | 850,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 16,688,636 | $191,919,314 | 67.54% |
| Cormorant Asset Management, LP | 9,923,689 | $114,122,424 | 6.66% |
| COMMODORE CAPITAL LP | 3,518,556 | $40,463,394 | 4.73% |
| Ally Bridge Group (NY) LLC | 281,089 | $3,232,524 | 3.79% |
| Paradigm Biocapital Advisors LP | 3,488,596 | $40,118,854 | 2.72% |
| VR Adviser, LLC | 2,070,000 | $23,805,000 | 2.51% |
| Ghost Tree Capital, LLC | 525,000 | $6,037,500 | 1.99% |
| HighVista Strategies LLC | 193,701 | $2,227,562 | 1.03% |
| Ikarian Capital, LLC | 4,932 | $5,671,800 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 34,000 | $391,000 | 0.51% |